Share this
Cytokinetics – $450 Million Convertible Senior Notes Offering
Portola Agrees to Sell to Alexion for $1.41 Billion
Cell Design Labs Sells to Gilead
Cell Design Labs: Collaboration Agreement with Kite Pharma and Simultaneous Series of Private Financings
Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan
NewLink Genetics Signs $1 Billion Deal with Genentech for Cancer Drug Research & Development